Longitudinal Retinal Changes in MOGAD
dc.contributor.author | Oertel, Frederike Cosima | |
dc.contributor.author | Sotirchos, Elias S. | |
dc.contributor.author | Zimmermann, Hanna G. | |
dc.contributor.author | Motamedi, Seyedamirhosein | |
dc.contributor.author | Specovius, Svenja | |
dc.contributor.author | Asseyer, Eva Susanna | |
dc.contributor.author | Chien, Claudia | |
dc.contributor.author | Cook, Lawrence | |
dc.contributor.author | Vasileiou, Eleni | |
dc.contributor.author | Filippatou, Angeliki | |
dc.contributor.author | Calabresi, Peter A. | |
dc.contributor.author | Saidha, Shiv | |
dc.contributor.author | Pandit, Lekha | |
dc.contributor.author | D’Cunha, Anitha | |
dc.contributor.author | Outteryck, Olivier | |
dc.contributor.author | Zéphir, Hélène | |
dc.contributor.author | Pittock, Sean | |
dc.contributor.author | Flanagan, Eoin P. | |
dc.contributor.author | Bhatti, M. Tariq | |
dc.contributor.author | Rommer, Paulus S. | |
dc.contributor.author | Bsteh, Gabriel | |
dc.contributor.author | Zrzavy, Tobias | |
dc.contributor.author | Kuempfel, Tania | |
dc.contributor.author | Aktas, Orhan | |
dc.contributor.author | Ringelstein, Marius | |
dc.contributor.author | Albrecht, Philipp | |
dc.contributor.author | Ayzenberg, Ilya | |
dc.contributor.author | Pakeerathan, Thivya | |
dc.contributor.author | Knier, Benjamin | |
dc.contributor.author | Aly, Lilian | |
dc.contributor.author | Asgari, Nasrin | |
dc.contributor.author | Soelberg, Kerstin | |
dc.contributor.author | Marignier, Romain | |
dc.contributor.author | Tilikete, Caroline Froment | |
dc.contributor.author | Cobo Calvo, Alvaro | |
dc.contributor.author | Villoslada, Pablo | |
dc.contributor.author | Sanchez-Dalmau, Bernardo | |
dc.contributor.author | Martinez-Lapiscina, Elena H. | |
dc.contributor.author | Llufriu, Sara | |
dc.contributor.author | Green, Ari J. | |
dc.contributor.author | Yeaman, Michael R. | |
dc.contributor.author | Smith, Terry J. | |
dc.contributor.author | Brandt, Alexander U. | |
dc.contributor.author | Chen, John | |
dc.contributor.author | Paul, Friedemann | |
dc.contributor.author | Havla, Joachim | |
dc.contributor.author | Altintas, Ayse | |
dc.date.accessioned | 2022-09-26T16:05:25Z | |
dc.date.available | 2023-10-26 12:05:23 | en |
dc.date.available | 2022-09-26T16:05:25Z | |
dc.date.issued | 2022-09 | |
dc.identifier.citation | Oertel, Frederike Cosima; Sotirchos, Elias S.; Zimmermann, Hanna G.; Motamedi, Seyedamirhosein; Specovius, Svenja; Asseyer, Eva Susanna; Chien, Claudia; Cook, Lawrence; Vasileiou, Eleni; Filippatou, Angeliki; Calabresi, Peter A.; Saidha, Shiv; Pandit, Lekha; D’Cunha, Anitha; Outteryck, Olivier; Zéphir, Hélène ; Pittock, Sean; Flanagan, Eoin P.; Bhatti, M. Tariq; Rommer, Paulus S.; Bsteh, Gabriel; Zrzavy, Tobias; Kuempfel, Tania; Aktas, Orhan; Ringelstein, Marius; Albrecht, Philipp; Ayzenberg, Ilya; Pakeerathan, Thivya; Knier, Benjamin; Aly, Lilian; Asgari, Nasrin; Soelberg, Kerstin; Marignier, Romain; Tilikete, Caroline Froment; Cobo Calvo, Alvaro; Villoslada, Pablo; Sanchez-Dalmau, Bernardo ; Martinez-Lapiscina, Elena H. ; Llufriu, Sara; Green, Ari J.; Yeaman, Michael R.; Smith, Terry J.; Brandt, Alexander U.; Chen, John; Paul, Friedemann; Havla, Joachim; Altintas, Ayse (2022). "Longitudinal Retinal Changes in MOGAD." Annals of Neurology 92(3): 476-485. | |
dc.identifier.issn | 0364-5134 | |
dc.identifier.issn | 1531-8249 | |
dc.identifier.uri | https://hdl.handle.net/2027.42/174844 | |
dc.publisher | John Wiley & Sons, Inc. | |
dc.title | Longitudinal Retinal Changes in MOGAD | |
dc.type | Article | |
dc.rights.robots | IndexNoFollow | |
dc.subject.hlbsecondlevel | Psychiatry | |
dc.subject.hlbtoplevel | Health Sciences | |
dc.description.peerreviewed | Peer Reviewed | |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/174844/1/ana26440_am.pdf | |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/174844/2/ana26440.pdf | |
dc.identifier.doi | 10.1002/ana.26440 | |
dc.identifier.source | Annals of Neurology | |
dc.identifier.citedreference | Filippatou AG, Mukharesh L, Saidha S, et al. AQP4- IgG and MOG- IgG related optic neuritis- prevalence, optical coherence tomography findings, and visual outcomes: a systematic review and meta- analysis. Front Neurol 2020; 11: 540156. | |
dc.identifier.citedreference | Schmidt F, Zimmermann H, Mikolajczak J, et al. Severe structural and functional visual system damage leads to profound loss of vision- related quality of life in patients with neuromyelitis optica spectrum disorders. Mult Scler Relat Disord 2017; 11: 45 - 50. | |
dc.identifier.citedreference | Pache F, Zimmermann H, Mikolajczak J, et al. MOG- IgG in NMO and related disorders: a multicenter study of 50 patients. Part 4: afferent visual system damage after optic neuritis in MOG- IgG- seropositive versus AQP4- IgG- seropositive patients. J Neuroinflammation 2016; 13: 282. | |
dc.identifier.citedreference | Takai Y, Misu T, Kaneko K, et al. Myelin oligodendrocyte glycoprotein antibody- associated disease: an immunopathological study. Brain 2020; 143: 1431 - 1446. | |
dc.identifier.citedreference | Höftberger R, Guo Y, Flanagan EP, et al. The pathology of central nervous system inflammatory demyelinating disease accompanying myelin oligodendrocyte glycoprotein autoantibody. Acta Neuropathol 2020; 139: 875 - 892. | |
dc.identifier.citedreference | Jarius S, Metz I, König FB, et al. Screening for MOG- IgG and 27 other anti- glial and anti- neuronal autoantibodies in - pattern II multiple sclerosis- and brain biopsy findings in a MOG- IgG- positive case. Mult Scler 2016; 22: 1541 - 1549. | |
dc.identifier.citedreference | Spadaro M, Gerdes LA, Mayer MC, et al. Histopathology and clinical course of MOG- antibody- associated encephalomyelitis. Ann Clin Transl Neurol 2015; 2: 295 - 301. | |
dc.identifier.citedreference | Sotirchos ES, Filippatou A, Fitzgerald KC, et al. Aquaporin- 4 IgG seropositivity is associated with worse visual outcomes after optic neuritis than MOG- IgG seropositivity and multiple sclerosis, independent of macular ganglion cell layer thinning. Mult Scler 2019; 1352458519864928: 1360 - 1371. | |
dc.identifier.citedreference | Oertel FC, Outteryck O, Knier B, et al. Optical coherence tomography in myelin- oligodendrocyte- glycoprotein antibody- seropositive patients: a longitudinal study. J Neuroinflammation 2019; 16: 154. | |
dc.identifier.citedreference | Marignier R, Hacohen Y, Cobo- Calvo A, et al. Myelin- oligodendrocyte glycoprotein antibody- associated disease. Lancet Neurol 2021; 20: 762 - 772. | |
dc.identifier.citedreference | Balk LJ, Cruz- Herranz A, Albrecht P, et al. Timing of retinal neuronal and axonal loss in MS: a longitudinal OCT study. J Neurol 2016; 263: 1323 - 1331. | |
dc.identifier.citedreference | Motamedi S, Oertel FC, Yadav SK, et al. Altered fovea in AQP4- IgG- seropositive neuromyelitis optica spectrum disorders. Neurol Neuroimmunol Neuroinflamm 2020; 7: e805. | |
dc.identifier.citedreference | Sotirchos ES, Saidha S, Byraiah G, et al. In vivo identification of morphologic retinal abnormalities in neuromyelitis optica. Neurology 2013; 80: 1406 - 1414. | |
dc.identifier.citedreference | Filippatou AG, Vasileiou ES, He Y, et al. Optic neuritis- independent retinal atrophy in Neuromyelitis Optica Spectrum disorder. J Neuroophthalmol 2021; 42: e40 - e47. | |
dc.identifier.citedreference | Felix CM, Levin MH, Verkman AS. Complement- independent retinal pathology produced by intravitreal injection of neuromyelitis optica immunoglobulin G. J Neuroinflamm 2016; 13: 275. | |
dc.identifier.citedreference | Henderson APD, Altmann DR, Trip AS, et al. A serial study of retinal changes following optic neuritis with sample size estimates for acute neuroprotection trials. Brain 2010; 133: 2592 - 2602. | |
dc.identifier.citedreference | Costello F, Pan YI, Yeh EA, et al. The temporal evolution of structural and functional measures after acute optic neuritis. J Neurol Neurosurg Psychiatry 2015; 86: 1369 - 1373. | |
dc.identifier.citedreference | Ramanathan S, Prelog K, Barnes EH, et al. Radiological differentiation of optic neuritis with myelin oligodendrocyte glycoprotein antibodies, aquaporin- 4 antibodies, and multiple sclerosis. Mult Scler 2016; 22: 470 - 482. | |
dc.identifier.citedreference | Oertel FC, Havla J, Roca- Fernández A, et al. Retinal ganglion cell loss in neuromyelitis optica: a longitudinal study. J Neurol Neurosurg Psychiatry 2018; 89: 1259 - 1265. | |
dc.identifier.citedreference | Akaishi T, Nakashima I, Takeshita T, et al. Different etiologies and prognoses of optic neuritis in demyelinating diseases. J Neuroimmunol 2016; 299: 152 - 157. | |
dc.identifier.citedreference | Sato DK, Callegaro D, Lana- Peixoto MA, et al. Distinction between MOG antibody- positive and AQP4 antibody- positive NMO spectrum disorders. Neurology 2014; 82: 474 - 481. | |
dc.identifier.citedreference | Chen JJ, Sotirchos ES, Henderson AD, et al. OCT retinal nerve fiber layer thickness differentiates acute optic neuritis from MOG antibody- associated disease and multiple sclerosis: RNFL thickening in acute optic neuritis from MOGAD vs MS. Multiple Sclerosis and Related Disorders 2022; 58: 103525. Available at: https://www.msard-journal.com/article/S2211-0348(22)00040-2/fulltext. Accessed January 13, 2022. | |
dc.identifier.citedreference | R Development Core Team. R: a language and environment for statistical computing [internet]. Vienna, Austria: R Foundation for Statistical Computing, 2008 Available at: http://www.R-project.org. | |
dc.identifier.citedreference | Schippling S, Balk LJ, Costello F, et al. Quality control for retinal OCT in multiple sclerosis: validation of the OSCAR- IB criteria. Mult Scler 2015; 21: 163 - 170. | |
dc.identifier.citedreference | Tewarie P, Balk L, Costello F, et al. The OSCAR- IB consensus criteria for retinal OCT quality assessment. PLoS ONE 2012; 7: e34823. | |
dc.identifier.citedreference | Reindl M, Schanda K, Woodhall M, et al. International multicenter examination of MOG antibody assays. Neurol Neuroimmunol Neuroinflamm 2020; 7: e674. | |
dc.identifier.citedreference | Nolan RC, Galetta SL, Frohman TC, et al. Optimal Intereye difference thresholds in retinal nerve fiber layer thickness for predicting a unilateral optic nerve lesion in multiple sclerosis. J Neuroophthalmol 2018; 38: 451 - 458. | |
dc.identifier.citedreference | Jarius S, Paul F, Aktas O, et al. MOG encephalomyelitis: international recommendations on diagnosis and antibody testing. J Neuroinflammation 2018; 15: 134. | |
dc.identifier.citedreference | Oertel FC, Specovius S, Zimmermann HG, et al. Retinal optical coherence tomography in Neuromyelitis Optica. Neurol Neuroimmunol Neuroinflamm 2021; 8: e1068. Available at: https://nn.neurology.org/content/8/6/e1068. Accessed September 15, 2021. | |
dc.identifier.citedreference | Specovius S, Zimmermann HG, Oertel FC, et al. Cohort profile: a collaborative multicentre study of retinal optical coherence tomography in 539 patients with neuromyelitis optica spectrum disorders (CROCTINO). BMJ Open 2020; 10: e035397. | |
dc.identifier.citedreference | Sotirchos ES, Gonzalez Caldito N, Filippatou A, et al. Progressive multiple sclerosis is associated with faster and specific retinal layer atrophy. Ann Neurol 2020; 87: 885 - 896. | |
dc.identifier.citedreference | Petzold A, Balcer LJ, Calabresi PA, et al. Retinal layer segmentation in multiple sclerosis: a systematic review and meta- analysis. Lancet Neurol 2017; 16: 797 - 812. | |
dc.identifier.citedreference | Andorrà M, Alba- Arbalat S, Camos- Carreras A, et al. Using acute optic neuritis trials to assess neuroprotective and Remyelinating therapies in multiple sclerosis. JAMA Neurol 2020; 77: 234 - 244. | |
dc.identifier.citedreference | Syc SB, Saidha S, Newsome SD, et al. Optical coherence tomography segmentation reveals ganglion cell layer pathology after optic neuritis. Brain 2012; 135: 521 - 533. | |
dc.identifier.citedreference | Havla J, Kümpfel T, Schinner R, et al. Myelin- oligodendrocyte- glycoprotein (MOG) autoantibodies as potential markers of severe optic neuritis and subclinical retinal axonal degeneration. J Neurol 2017; 264: 139 - 151. | |
dc.working.doi | NO | en |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.